Unlock instant, AI-driven research and patent intelligence for your innovation.
A group of 2-amido-3-alkoxy substituted pyridine compounds and their new applications
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A compound and composition technology, applied in 2-amido-3-alkoxypyridine compounds, the preparation of the compound, the field of the pharmaceutical composition of the compound, to achieve good anti-atherosclerosis effect, broad The effect of the application foreground
Active Publication Date: 2018-09-25
MEDICINE & BIOENG INST OF CHINESE ACAD OF MEDICAL SCI
View PDF2 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
2-amido-3-alkoxy substituted pyridine compounds have no literature reports on the anti-atherosclerosis effect, which is the first discovery of this patent application
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0045] The preparation of embodiment 1N-(3-hydroxyl-2-pyridyl)-4-(1,3-dithio-2-cyclopentyl)benzamide (LX-1)
[0046] According to the operating method of Example 1, with 0.23g (0.001mol) 4-(1,3-dithio-2-cyclopentyl) benzoic acid and 0.11g (0.001mol) 2-amino-3-pyridinol Feed, to obtain LX-1 pure product 0.31g white solid, yield 97%. MS (ESI, m / z): 319[M]+, 1H NMR (500MHz, d6-DMSO) δ (ppm): 10.568 (s, 1H, NH-CO), 9.856 (s, 1H, -OH), 7.977(m, 2H, Ph-H), 7.655(m, 2H, Ph-H), 7.341(dd, 1H, J=8.0Hz, 1.5Hz, Py-6H), 7.224(dd, 1H, J=8.0 Hz, 5.0Hz, Py-4H), 5.843(s, 1H, SCHS), 5.337(t, 1H, J=5.0Hz, Py-5H), 3.57(m, 2H, CH2), 3.396(m, 2H, CH2)
Embodiment 2
[0047] The preparation of embodiment 2N-(3-hydroxyl-2-pyridyl)-4-trifluoromethoxybenzamide (LX-3)
[0048] According to the operating method of Example 1, 0.21g (0.001mol) 4-trifluoromethoxybenzoic acid and 0.11g (0.001mol) 2-amino-3-pyridinol were fed to obtain 0.25g of LX-3 pure product yellow Solid, 84% yield. MS (ESI, m / z): 299[M]+, 1H NMR (500MHz, d6-DMSO) δ (ppm): 8.151 (m, 1H, Ph-H), 7.960 (d, 1H, J=5.0Hz , Py-6H), 7.530(m, 1H, Ph-H), 7.326(d, 1H, J=7.5Hz, Py-4H), 7.203(m, 1H, NH-CO), 6.654(s, 1H, -OH), 5.337(t, 1H, J=5.0Hz, Py-5H),
Embodiment 3
[0049] The preparation of embodiment 3N-(3-hydroxyl-2-pyridyl)-4-iodobenzamide (LX-5)
[0050] According to the operation method of Example 1, feed intake with 0.25g (0.001mol) 4-iodobenzoic acid and 0.11g (0.001mol) 2-amino-3-pyridinol, obtain LX-5 pure product 0.36g white solid, the yield 90%. MS (ESI, m / z): 341[M]+, 1H NMR (500MHz, d6-DMSO) δ (ppm): 7.957 (s, 1H, NH), 7.924 (m, 2H, Ph-2H), 7.650 (s, 1H, Py-6), 7.323 (m, 2H, Ph-2H), 7.199 (s, 1H, OH), 5.337 (m, 2H, Py-4, 5H),
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention discloses 2-acylamino-3-alkoxyl substituted pyridine compounds and an application of the compounds in treatment and / or prevention of atherosclerosis-induced cardiovascular diseases. Experiments verify that the compounds or pharmaceutical compositions have the function of up-regulating or stabilizing ABCA1 and SR-BI / CLA-1 and can be used for inhibiting bubblization of macrophage or enhancing cholesterolefflux of macrophage. Experiments show that the compounds have the effects of reducing blood fat and cholesterol and have an application prospect of becoming a medicine for reducing blood fat, treating atherosclerosis, cardiovascular diseases and the like.
Description
technical field [0001] The present invention relates to a class of 2-amido-3-alkoxypyridine compounds, which are used in the treatment and / or prevention of atherosclerotic cardiovascular diseases and belong to the field of pharmacy; , SR-BI / CLA-1, the application of lipid-lowering and cholesterol-lowering drugs; the present invention also relates to the preparation method of the compound; the present invention also relates to the pharmaceutical composition of the compound. Background technique [0002] Cardiovascular disease is the main killer of human health in developed countries and most developing countries. In recent years, with the improvement of people's material living standards, the incidence of cardiovascular and cerebrovascular diseases has shown an obvious upward trend, and the death rate of cardiovascular and cerebrovascular diseases accounts for the The composition of population death has reached 1 / 3. Atherosclerosis is the pathological basis of many serious c...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to View More 
Login to View More 
